news PS - Columbia University Medical Center
news PS - Columbia University Medical Center
news PS - Columbia University Medical Center
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
• From the Dean<br />
Dear Readers,<br />
Inside this issue, you will find several examples of<br />
exciting progress here at <strong>Columbia</strong>: A profile of our<br />
newest Institute of Medicine member, Carol Mason; Tim<br />
Wang’s novel approach to the study<br />
of cancer; an exciting expansion of<br />
our <strong>Columbia</strong>Doctors practice in<br />
midtown Manhattan; an update on the<br />
scholarly projects of our inaugural<br />
class in the new M.D. curriculum;<br />
the experience of the first class<br />
of <strong>Columbia</strong>-Bassett students<br />
in Cooperstown; and a review of<br />
landmark research performed here<br />
at <strong>Columbia</strong> that demonstrates how<br />
we can now replace an aortic valve<br />
without surgery. The issue also<br />
profiles two accomplished physicianscientists<br />
and academic leaders:<br />
Paul Marks – a 1949 P&S graduate, former dean of P&S,<br />
and current CUMC Board of Visitors member – and his<br />
son, Andy Marks – our current chair of physiology &<br />
cellular biophysics. In the newly designed alumni section<br />
of the magazine, you can read profiles of three 1980s<br />
alumni who have had fascinating careers in biotechnology:<br />
Ron Cohen, Paul Maddon, and George Yancopoulos.<br />
These examples of our people and our achievements<br />
serve as true measures of our success, but we also<br />
appreciate when external evaluations publicly reinforce<br />
the value of our contributions to the fields of medicine,<br />
education, and biomedical science. In 2011, our National<br />
Institutes of Health awards grew by more than 6 percent,<br />
demonstrating how well our faculty are doing when<br />
competing against their peers for research funding at a<br />
time when the overall NIH budget declined. In education,<br />
we proudly note that the yield for our first-year class –<br />
the percentage of accepted students who enrolled – was<br />
the highest in 35 years. Another indicator is our recordbreaking<br />
philanthropy, which last year topped $200 million<br />
in support that we gratefully acknowledge from alumni,<br />
patients, and other friends.<br />
However, no external assessment exemplifies the<br />
greatness of P&S better than the highest standard we<br />
set for ourselves – our unwavering commitment to<br />
improving health throughout the world with advances in<br />
medical education, scientific research, and patient care.<br />
With best wishes,<br />
Lee Goldman, M.D., Dean<br />
lgoldman@columbia.edu<br />
departments<br />
2<br />
4<br />
14<br />
29<br />
31<br />
44<br />
48<br />
Letters<br />
P&S News<br />
Clinical Advances<br />
ECMO for Adults Makes a Comeback<br />
Integrated Arthritis <strong>Center</strong>: Applying Research to Patient Care<br />
For Sleep Apnea, Robotic Surgery Offers a New Tool<br />
Forestalling Lymphedema, a Preventive Strategy<br />
Graduate School Life<br />
Several students in the Graduate Program in Pharmacology<br />
and Molecular Signaling use sophisticated techniques to lay the<br />
groundwork for the design of more potent and specific drugs.<br />
Alumni News & Notes<br />
Alumni Profile: Biotech leaders Ron Cohen, Paul Maddon,<br />
and George Yancopoulos<br />
In Memoriam<br />
Faculty and alumni who have died<br />
P&S Club Corner<br />
29